Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07214597 · ClinicalTrials.gov registry record · NA

NICU Utilization of Remote Voice Technology to Improve mateRnal Experience (NURTURE)

A NA study of Self Efficacy and Engagement, Patient, sponsored by Vanderbilt University Medical Center.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT07214597: Recruiting NA study of Self Efficacy and Engagement, Patient, sponsored by Vanderbilt University Medical Center.

NCT07214597 is a NA study of Self Efficacy and Engagement, Patient that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 150 participants, roughly in line with the 149-participant average among 30 other Self Efficacy trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07214597, a NA study of Self Efficacy and Engagement, Patient, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The study's objective is to conduct a Phase II randomized controlled trial examining the preliminary efficacy of the VoiceLove app compared to usual care on maternal postpartum depression in mothers with infants admitted to the Neonatal Intensive Care Unit (NICU). Primary aim: Assess the effects of VoiceLove on maternal postpartum depression, measured by the Edinburgh Postnatal Depression Scale (EPDS). The estimates from this study will be used for a future definitive Phase III trial. Secondary aim: Assess feasibility, acceptability, and patterns of communication and engagement among mothers, partners, and NICU clinicians during the NICU hospitalization, measured through app usage metrics, satisfaction surveys, and qualitative interviews. Additionally, we will evaluate effects of infant length of stay.

Primary Outcome

To assess the feasibility of using the VoiceLove app, we will measure how much patients in the intervention group engage with the app using metrics such as average app use per day at 2-weeks post randomization.

Interventions

  • DEVICE VoiceLove mobile phone application

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2026-02-04
Est. Completion 2028-01
Phase NA

What NCT07214597 shows while recruiting

NCT07214597 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 149-participant average among 30 other Self Efficacy trials with a reported enrollment target.

The record links to 6 conditions, with Self Efficacy appearing as the primary indexed condition, and to 1 intervention - of which VoiceLove mobile phone application is the first listed.

NCT07214597 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT07214597 about?

NCT07214597 is a clinical study titled "NICU Utilization of Remote Voice Technology to Improve mateRnal Experience (NURTURE)". The study's objective is to conduct a Phase II randomized controlled trial examining the preliminary efficacy of the VoiceLove app compared to usual care on maternal postpartum depression in mothers with infants admitted to the Neonatal Intensive Care Unit (NICU). Primary aim: Assess the effects of ...

What is the current status of trial NCT07214597?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2026-02-04. Estimated completion is 2028-01.

What conditions does trial NCT07214597 study?

This clinical trial studies the following conditions: Self Efficacy, Engagement, Patient, Postpartum Depression (PPD), Length of Stay, Usability.

What interventions are being tested in trial NCT07214597?

The interventions under investigation include: VoiceLove mobile phone application (DEVICE).

Who is sponsoring clinical trial NCT07214597?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07214597 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Self Efficacy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07214597's enrollment target sits among peer trials

150 8th of 30 higher than 23 of 30 other Self Efficacy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Self Efficacy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07214597, the US trial registry maintained by the National Library of Medicine. NCT07214597 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.